|
- 2017
维生素D对大鼠肾上腺嗜铬细胞瘤PC12细胞中神经酰胺水平的影响
|
Abstract:
[1] | Martinelli V, Dalla Costa G, Colombo B. Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes[J]. Mult Scler, 2014, 20(2):147-155. |
[2] | Spach KM, Hayes CE. Vitamin D3 confers protcttion from autimmune encephalomyelit is only in female mice[J]. J Immunol, 2005, 175(6):4119-4126. |
[3] | Susanne S, Ferreiros N, Birod K. Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis[J]. J Immunol, 2012, 188(11):5723-5733. |
[4] | Hojjati MR, Li Z, Jiang XC. Serine palmitoyl-CoA transferase(SPT)deficiency and sphingolipid levels in mice[J]. Biochim Biophys Acta, 2005, 1737(1):44-51. |
[5] | Grigoriadis N, Van Pesch V. A basic overview of multiple sclerosis immunopathology[J]. Eur J Neurol, 2015, 22(2):3-13. |
[6] | Macchi B, Marino-Merlo F, Nocentini U, et al. Role of inflammation and apoptosis in multiple sclerosis: comparative analysis between the periphery and the central nervous system[J]. J Neuroimmunol, 2015, 287:80-87. doi:10.1016/j.jneuroim.2015.08.016. |
[7] | Gomez-Mu(~overn)oz A, Presa N, Gomez-Larrauri A. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate[J]. Prog Lipid Res, 2016, 61:51-62. doi: 10.1016/j.plipres.2015.09.002. |
[8] | Zhu Y, Qin Z, Gao J. Vitamin D therapy in experimental allergic encephalomyelitis could be limited by opposing effects of sphingosine-1-phosphate and gelsolin dysregulation[J]. Mol Neurobiol, 2014, 50(3):733-743. |
[9] | Hoveizi E, Tavakol S, Ebrahimi-Barough S. Neuroprotective effect of transplanted neural precursors embedded on PLA/CS scaffold in an animal model of multiple sclerosis[J]. Mol Neurobiol, 2015, 51(3):1334-1342. |
[10] | Hartfield PJ, Manyne GC, Murray AW. Ceramide induces apoptosis in PC12 cells[J]. FEBS Letters, 1997, 401(2-3):148-152. |
[11] | Michael M, Sarah S. Sphingolipid metabolites in inflammatory disease[J]. Nature, 2014, 510(7503): 58-67. |
[12] | Dyment DA, Yee IM, Ebers GC. Multiple sclerosis in stepsiblings: recurrence risk and ascertainmen[J]. J Neurol Neurosurg Psychiatry, 2006, 77(2):258-259. |
[13] | Beecham AH, Patsopoulos NA, Xifara DK. International multiple slerosis genetics consortium(IMSGC), analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis[J]. Nat Genet, 2013, 45(11):1353-1360. |
[14] | Ben-David O, Futerman AH. The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases[J]. Neuromolecular Med, 2010, 12(4):341-350. |
[15] | Cross AH, Naismith RT. Established and novel disease-modifying treatments in multiple sclerosis[J]. J Intern Med, 2014, 275(4):350-363. |
[16] | Smolders J, Damoiseaux J, Menheere P. Vitamin D as an immune modulator in multiple sclerosis, a review[J]. J Neuroimmunology, 2008, 194(1): 7-17. |
[17] | Scott TF, Hackett CT, Dworek DC. Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients[J]. J Neurol Sci, 2013, 330(1-2): 27-31. |
[18] | Dai L, Trillo-Tinoco J, Bai A, et al. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression[J]. Oncotarget, 2015, 6(27): 24246-24260. |
[19] | Saddoughi SA, Ogretmen B. Diverse functions of ceramide in cancer cell death and proliferation[J]. Adv Cancer Res, 2013, 117:37-58. doi: 10.1016/B978-0-12-394274- 6.00002-9. |
[20] | Ohno Yusuke, Nakamichi S, Ohkuni A. Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation[J]. PNAS, 2015, 112(25):7707-7712. |